StockNews.com Begins Coverage on Avinger (NASDAQ:AVGR)
by Danessa Lincoln · The Markets DailyEquities researchers at StockNews.com started coverage on shares of Avinger (NASDAQ:AVGR – Get Free Report) in a note issued to investors on Tuesday. The firm set a “hold” rating on the medical device company’s stock.
Avinger Stock Performance
Avinger stock opened at $0.47 on Tuesday. The stock has a market capitalization of $1.57 million, a price-to-earnings ratio of -0.04 and a beta of 1.09. Avinger has a 52-week low of $0.36 and a 52-week high of $4.37. The stock’s 50 day moving average price is $0.52 and its two-hundred day moving average price is $0.76.
Avinger Company Profile
Avinger, Inc, a commercial-stage medical device company, designs, manufactures, and sells a suite of image-guided and catheter-based systems used by physicians to treat patients with peripheral artery disease (PAD) primarily in the United States and Germany. The company develops lumivascular platform that integrates optical coherence tomography visualization with interventional catheters to provide real-time intravascular imaging during the treatment portion of PAD procedures.
Featured Stories
- Five stocks we like better than Avinger
- 3 Ways To Invest In Coffee, Other Than Drinking It
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- NYSE Stocks Give Investors a Variety of Quality Options
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Most active stocks: Dollar volume vs share volume
- D-Wave and Quantum Supremacy: Implications For Investors